Dr. Miller’s Presentations

By State/Area  [By Audience Type]

Washington DC Area or National:

  • “Developing Evidence and Making the Case for Coverage,” AdvaMed Medical Reimbursement 201 Workshop, June 28, 2017
  • “Shaping the Policy Agenda for Access to Care for Women with Heart Disease,” Keynote at KOLs Workshop on Access to Care for Women with Heart Disease organized by WomenHeart, April 5, 2017
  • “Framework for the Future of the U.S. Healthcare System: What Comes After ObamaCare?,” HealthyWomen Networking Breakfast, Washington, DC, February 14, 2017
  • “Health Reform in 2014: Opportunities & Challenges for Physicians,” Medical Society of Alabama, Washington, DC, February 10, 2014
  • “Employer Perspectives on Health Promotion and Disease Prevention,” Georgetown University, February 14, 2013
  • “Genetics, Literacy and Data Collection/Monitoring in Health Disparities,” George Washington University School of Public Health, PubH376: Understanding and Eliminating Health Disparities, October 20, 2009
  • “Health Benefits Laws & Legislation,” George Washington University School of Law, “Employment Law,” Washington, DC, November 10, 2003
  • Briefing Moderator, “The Long Road to Discovery: The Challenging Search for New Cures for Cancer,”  Washington, DC, June 24, 2003
  • Fox Cable News, “Purchasing Medicines from Canada,” January 14, 2003
  • “Prescription Drugs, Prices and TV Ads,” National Public Radio, “Talk of the Nation,” April 9, 2002 [listen from NPR audio]
  • Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, Arlington, VA May 7-8, 2002
  • “Pharmaceutical Innovation & Issues,” The New England Council Congressional Staff Briefing, 1116 Longworth House Office Building, Washington, DC, January 30, 2002
  • “Pharmaceutical Issues in Washington – The Industry View,” American Osteopathic Association Council on Federal Health Programs, Washington, DC, January 18, 2002
  • Testimony Before the United States Senate’s Committee on Veterans’ Affairs, Hearing on Prescription Drug Issues in the Department of Veterans Affairs, July 24, 2001
  • “Pharmaceutical Industry Issues,” Georgetown Policy & Business in Medicine Seminar, Georgetown University School of Medicine, January 12, 2001
  • “Utilizing Manufacturer Patient Assistance Programs: New Industry Efforts and Provider Feedback,” 340B Coalition Annual Conference, Washington, DC, July 20, 2000
  • “Access to Prescription Drugs, Pharmaceutical Research & Quality Healthcare,” Northern Virginia Access to Health Care Consortium, Annandale, VA, May 25, 2000
  • “Quality Health Care: The Right Drug for the Right Patient at the Right Time,” Foundation for Veterans’ Healthcare, “Veterans Healthcare: A New Millennium, A New Administration, A New Approach?” Washington, DC, May 11, 2000
  • “It’s About Coverage, Not Price,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?,” Washington, DC, April 13, 2000
  • “The Value of Innovation – For Patients, the Health Care System, and Society,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?” Washington, DC, April 13, 2000
  • “Medicare & Prescription Drugs,” National Alliance for the Mentally Ill Legislative and Leadership Conference, Washington, DC, February 7, 2000


  • “MCH and Health Reform in the States: Activities and Opportunities,” University of Alabama Birmingham, The Lister Hill Center for Health Policy & The Alabama Maternal & Child Health (MCH) Leadership Network, October 24, 2013


  • “Epigenetics and Regulating Genes: Implications for MCH in Arizona,” Arizona Improving Birth Outcomes Summit, Phoenix, AZ, January 7, 2014
  • “Prescription Drugs – Overview & Updates,” John C. Lincoln Health Network and Medical Staff Retreat, Sedona, AZ, June 3, 2000


  • “Pharmaceuticals: Access, Costs and Other Issues,” Arkansas Society of the American College of Osteopathic Family Physicians, Hot Springs, AR, March 21, 2002


  • “Tele-ICU Technology Profile,” Presentation to New England Healthcare Institute’s FAST Initiative Steering Committee, San Francisco CA, May 11, 2006
  • Participant, “The Biological Challenge: Exploiting the Opportunities and Managing the Risks” Center for Global Security Research; Chemical, Biological Arms Control Institute; International Institute for Strategic Studies, Lawrence Livermore National Laboratory, April 11-12, 2002
  • Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, March 12-13, 2002
  • “Pharmaceutical Industry Issues: Access, Costs, R&D, and Information,” The Forum for Medical Affairs, AMA House of Delegates Meeting, San Francisco, CA, December 3, 2001
  • “Global Access to Affordable Treatment: The Current Medications Controversy,” 13th Annual HIV/AIDS Update Conference, San Francisco, CA, March 23, 2001


  • “State Leadership Retreats: Multi-Stakeholder Alignment,” NAIC’s Health Care Reform Alternatives Working Group, Orlando, FL, March 30, 2014
  • “Finding Cures for Heart Disease Through Innovative Pharmaceutical Research,” Nova Southeastern University, Fort Lauderdale, FL, February 8, 2001
  • “Medicare & Prescription Drugs: Year 2000 and Beyond,” AACE Corporate Advisory Board, Jacksonville, FL, February 4, 2000


  • “Medication Development and Approval Process,” Georgia Academy of Family Physicians 53rd Annual Scientific Assembly, Atlanta, GA, December 1, 2001


  • “The Future of the US Healthcare System,” Keynote Address to the Organization of State Medical Association Presidents, Chicago, IL, June 13, 2003


  • “State and National Pharmaceutical Issues,” Southeastern Socioeconomic and Family Practice Forum, Louisville, KY, August 10, 2001


  • “Health System Reform,” MedChi (Maryland Medical Society) Health System Reform Task Force, Kent Island, MD, July 14, 2001


  • “Medicare Part D: Case Example of Federal Health Policy,” Northeastern University Health Policy Class (BHSU515), Boston, MA, March 25, 2009
  • “Health Reform 2009 and Beyond: Implications for Physicians, Patients, Hospitals, and the Economy, etc.” Caritas Carney Hospital, Boston, MA, March 11, 2009
  • “Implications of the Next Presidential Administration for Life Sciences Companies,” Yale Life Sciences Alumni Association, Boston, MA, October 21, 2008
  • “Rising Health Policy Leaders Forum,” Massachusetts General Hospital Department of Medicine, May 8, 2008
  • “AAAS Science and Technology Policy Fellowship Workshop,” Panel Presentation at AAAS Annual Meeting, Boston MA, February 16, 2008
  • “Pricing and Reimbursement as Factors for Life Science Company’s Valuation,” MIT Enterprise Forum of Cambridge’s Life Sciences Special Interest Group,” March 14, 2005
  • “Insights to Marketing: Career Advice & Professional Experiences,” Simmons Consulting Group, Simmons School of Management, Boston MA, February 14, 2005
  •  “Life Sciences Business Creation,” NETS – New Entrepreneur in Technology and Science, SHARE / Consulate of Switzerland, Cambridge MA, June 14, 2004
  • “From Idea to Reality: Turning a Lab Discovery into a Commercial Product,” Tufts University Bioengineering Center & Biomedical Engineering Department, February 27, 2004
  • “Pharmaceutical-Biotech Intellectual Property & Market Issues,” Wolf, Greenfield & Sacks, Boston, MA, June 19, 2003
  • “Public Policy and The Media: What’s the Story,” Tufts University Friedman School of Nutrition Science and Policy, NUTR0240-01: Theories of Public Policy, April 16, 2003
  • “Roles and Responsibilities of Non-Profit Boards & Board Members,” Williams College Winter Study Class, “Philanthropy and The Social Entrepreneur,” January 22, 2003
  • “The Patient and the Pharmaceutical Industry?  David and Goliath Without the Happy Ending,” 10th Annual Peter Mareb Lecture Series at Stonehill College’s Martin Institute for Law and Society, Easton, MA, April 26, 2001


  • Testimony Before Missouri House of Representatives Interim Committee on Access to Affordable Prescription Drugs for Senior Citizens, St. Louis, MO, December 5, 2000
  • “Update on Medicare & Prescription Drugs Issues: Looking to 2001 and Beyond,” AACE Corporate Advisory Board, St. Louis, MO, November 3, 2000

New York:

  • “Prescription Drug ‘Costs’,” Empire State Report’s 6th Annual Healthcare Conference, New York, NY, May 24, 2001
  • “Affordable Prescription Drugs: Why? Why Not?” Manhattan Borough-Wide Inter-Agency Council On Aging, Sixth Annual Breakfast Forum, Terence Cardinal Cooke Health Care Center, New York, NY, October 20, 2000


  • “Prescription Drug Cost and Access: Pharmaceutical Industry Perspective,” Oklahoma State Medical Association 95th Annual Meeting, Saturday April 28, 2001


Rhode Island:

  • “Healthcare Policy & Politics,” Brown University Department of Political Science and Public Policy, “PS 110: Congress and Public Policy,” March 6, 2003


  • “Trends and Treatments in Women’s Health,” Keynote Address, Senior Women’s Health Forum Baptist Hospital, Nashville, TN, June 8, 2000


  • “The Production of Pharmaceuticals Overseas:  Implications for US Physicians and Patients,” American Association of Clinical Endocrinologists (AACE) Corporate Advisory Board, San Antonio, TX, May 2, 2001
  • “Walking the Tightrope: Stretching the Pharmacy Dollar,” Panel, Texas Pharmacy Association Annual Meeting, Austin, TX, June 23, 2000
  • “Overview of the Pharmaceutical Market – Prescription Drugs & Healthcare: Year 2000 and Beyond,” HMO Alliance Board of Directors Meeting, Dallas, TX, February 24, 2000


  • “Access: What is Being Done,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
  • “Reaction Panel:  An In-Depth Look at Price,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
  • ”What Can Be Done to Reduce Prescription Drug Bills Now?” Community Forum Hosted by Vermont State Representatives Margaret Flory, Kevin Mullin and Thomas Depoy, Godnick Adult Center, Rutland, VT, October 17, 2000


  • “Health, Healthcare, and Government Budgets,” George Mason University, Schar School of Policy and Government, September 29, 2016
  • “Health Reform and Fiscal Challenges: Health Policy is Budget Policy (and Political Policy),” George Mason University School of Policy, Government and International Affairs, February 18, 2016
  • “Health Reform and Fiscal Challenges: Health Policy is Budget Policy,” George Mason University School of Policy, Government and International Affairs, February 19, 2015
  • “Government Financial Policy: Health & Healthcare,” George Mason University School of Policy, Government and International Affairs, September 23, 2014
  • “State Level Health Transformation: Factors and Visions,” George Mason University School of Public Policy, June 30, 2014
  • “Government Fiscal Issues: Healthcare,” University of Virginia Batten School of Public Policy, February 18, 2013
  • “Medicare and Obamacare,” The Envoy, Alexandria VA, October 10, 2012
  • “A Conversation on President Obama’s Health Care Policies,” Commonwealth Healthcare and Rehab, Fairfax VA, October 9, 2012
  • “Discussion of Healthcare, Medicare, Medicaid and Social Security Policies,” Woodbine Rehabilitation & Healthcare, Alexandria, VA, October 8, 2012
  • “Changes to Medicare and the Election,” The Hermitage, Alexandria VA, October 5, 2012
  • “A Conversation on President Obama’s Health Care Policies,” ManorCare, Arlington VA, October 3, 2012
  • “A Conversation on President Obama’s Health Care Policies,” The Woodlands, Fairfax VA, October 3, 2012
  • “Value in Healthcare: Unraveling the Equation,” Virginia Association of Health Underwriters, Richmond, VA, April 23, 2002
  • “What Can We Do About Drug Costs?,” Panel Discussion at Central Shenandoah Valley Health Care Coalition Annual Seminar “Employers’ Perspectives on Health Care Costs: Nowhere But Up?,” Staunton, VA, December 1, 2000
  • “Medicare & Prescription Drugs:  2000 and Beyond,” Virginia Quality Healthcare Network, Richmond, VA, May 12, 2000


  • “Prescription Drug: How Can We Balance Care, Costs and Access?,” The O’Connor Report Invitational Healthcare Leadership Forum, Seattle, WA, June 1, 2001